Utilization of Hypofractionated Whole-Breast Radiotherapy with Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy. - Sayan, M.; Vergalasova, I.; Jhawar, S.R.; Toppmeyer, D.; Haffty, B.G.; Ohri, N. (International Journal of Radiation Oncology, Biology, Physics, 2019)